chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shot mandated by employer or my husband would be fired from job.  Patient got J&J death shot on 9/9/21 at local grocery store.  April 2022 Patient had 1 episode of blood in urine.  Could not get any appointment with Urologist any sooner.  Patient saw a Urologist. He performed (weeks later due to no appointments available) a cystoscopy and saw 1 tumor in the bladder.  Patient had outpatient surgery on 6/1/22 for tumor removal which was successful - only 1 tumor in there and he got it all.  On 6/9/22 Patient was told that the tumor was the WORST type - very rare, very aggressive Stage 4 Bladder Cancer.  Patient was sent to Oncology where that MD said due to type of cancer there was nothing they could do to cure this, they had only 2 platinum chemo agents available to offer in the hope to prolong his life. Oncology in gave 2nd opinion of the same thing as if reading from a script. Patient then researched the 2 platinum chemo agents and was horrified at the results - death as a side effect and complete loss of immune function. Patient sought treatment from a Cancer Center for 2 months out of pocket.  His tests and labs showed promise.  After returning, a few weeks into treatments, patient began to turn yellow (bilirubin/liverfailure).  It was determined that the rare aggressive bladder cancer had overtaken his liver.  Patient was hospitalized in September 2022 and not one employee told us what was going on wih him.  My husband was given morphine and IV fluids and left in a bed.  He was discharged after the hospitalist came into his room asking:  "So what do you want us to do for you".  He came home and we made arrangements for hospice.  He was on hospice 2 weeks and died on 10/1/2022 from the death shot.
Within an hour headache ,stomach ache, cough, exhaustion . After 10 days went in for Covid test per Dr.s orders. Came back neg. But had small bruise on arm below injection site that night. All symptoms resolved with in 2 weeks except bruising. Keep getting small bruises on arms and legs. Most are only about the size of a pea but now have one on forearm size of half dollar with 2 smaller ones just below it.
joint pain on the right side; full breakout of body rash; really bad left jaw pain - excruciation pain; soreness on left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (really bad left jaw pain - excruciation pain), RASH (full breakout of body rash), PAIN IN EXTREMITY (soreness on left arm) and ARTHRALGIA (joint pain on the right side) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028H21A or 028H21H) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness on left arm). On 05-Apr-2021, the patient experienced PAIN IN JAW (really bad left jaw pain - excruciation pain). On 09-Apr-2021, the patient experienced RASH (full breakout of body rash). On an unknown date, the patient experienced ARTHRALGIA (joint pain on the right side). On 02-Apr-2021, PAIN IN EXTREMITY (soreness on left arm) had resolved. On 09-Apr-2021, PAIN IN JAW (really bad left jaw pain - excruciation pain) outcome was unknown, ARTHRALGIA (joint pain on the right side) had resolved. At the time of the report, RASH (full breakout of body rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included clindamycin.
On 4/11/00, the pt received her first injection of Lymerix without any reported event. On 5/15/00, the second injection of Lymerix was given. Approximately two months later, in late July, 2000, the pt experienced joint pain of the knees and fingers. The pt has not been evaluated by a physician and has not received treatment for the joint pain. At the time of the report, the event was ongoing.
I had my annual check up with my physician here on Sept 23rd.   They recommended and gave me the inoculation that day... it for people over 65.  Hives started soon after. The main itching and hives didn't show in full force until Sunday the 28th, but had probably been coming on and I didn't pay any attention to it.  Mon. I went back to the Dr. and she advised me to use  antihisimines.  She gave me a prescription for predispose but said try to get by with out it.  The break out has been just about everywhere on my body, not much on my face or in my hair.  In my crotch, legs, arms. hands, feet, back, front.  Today I decided to stop taking the antihistamine as the rash is settling down a lot .
stool was dark red; stool was very bright after flushing; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (stool was very bright after flushing) and FAECES DISCOLOURED (stool was dark red) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0S4C21A and 002F21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Aug-2021, the patient experienced FAECES DISCOLOURED (stool was very bright after flushing). On 15-Aug-2021, the patient experienced FAECES DISCOLOURED (stool was dark red). At the time of the report, FAECES DISCOLOURED (stool was very bright after flushing) and FAECES DISCOLOURED (stool was dark red) outcome was unknown.            The patient reported that he doesn't take any treatment for event but took  just water and orange juice.   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2021: Follow up received on 15-Aug-2021 contains initial additional information-Updated the batch/Lot num of second dose.
Left arm swelling, pain, warm, muscle tightness. 80 mg of Depo Medrol given IM.
Slight left side face and lip droop; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6199), via an unspecified route of administration in left arm on 05Mar2021 08:00 as single dose for COVID-19 immunization. Patient had COVID prior vaccination. The patient had no known allergies and no other medical history. The patient was not pregnant. There were no concomitant medications. There were no other vaccine in four weeks and no other medications in two weeks. The patient experienced slight left side face and lip droop on 05Mar2021 09:30. There was no treatment for the event. The patient was not COVID tested post vaccination. The outcome of the event was not recovered.
muscle spasms rt shoulder, arm, hand (extreme);when pt not taking anti-inflammatory pain returns;took Darvocet for 2wk, Vicodin for 3wk, ATB, muscle relaxlants, anti inflammatory for 3.5mo;saw MD;still wrist pain & hand pain;
THE INDIVIDUAL RECEIVED LESS THAN 0.5ML OF THE JANSSEN COVID-19 VACCINE AS A BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 62 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient received covid-19 vaccine ad26.cov2.s from unspecified manufacturer (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported (dose number in series 1), 1 in total administered for prophylactic vaccination. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A and expiry: 11-APR-2022) dose was not reported (dose number in series 2), 1 total, administered on right arm, on 01-DEC-2021 for prophylactic vaccination which was an off label use as patient received less than 0.5ml of the Janssen covid-19 vaccine as a booster dose (LLT: Vaccine underdose). No concomitant medications were reported.  As per the report, "the HCP withdrew 8 doses of the Janssen Covid-19 vaccine from 5 vials and 7 doses from 1 vial which injected into 48 individuals. When the caller had a discussion with that HCP, mentioned that he/she injected 0.5mL but the caller mentioned that the math (she arrived at that by dividing 2.5mL by 5 doses) did prove that they received approximately around 0.3mL."(dose number in series 2) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received less than 0.5 ml (approximately around 0.3 ml) of vaccine as a booster dose and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to  20211210197, 20211210067, 20211209551, 20211209976, 20211210058, 20211210160, 20211210588, 20211210610, 20211209775, 20211210159, 20211210409, 20211210733, 20211210408, 20211209880, 20211210133, 20211209816, 20211209782, 20211212088, 20211212082, 20211209679, 20211209740, 20211210670, 20211210824, 20211210350, 20211209912, 20211209706, 20211209843, 20211209921, 20211210019, 20211210112, 20211209798, 20211209874, 20211209884, 20211210549, 20211210106, 20211210107, 20211210143, 20211210165, 20211210180, 20211210334, 20211210385, 20211210585, 20211210590, 20211210662, 20211210684 and 20211210555.
Administered after expiration date; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number z9mz2, expiry date 3rd December 2021) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th March 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 9th March 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The medical assistant stated about administration of Kinrix after expiration date, which led to expired vaccine used. The reporter consented for follow up.
Monovalent vaccine administered instead of the Bivalent Booster. No adverse effects. Patient is doing well.
Pt recvd vax & exp flu-like sx; 24 hrs p/vax exp fever, plugged ears, & abdo pain;
Information has been received from a consumer and a licensed practical nurse, through the pregnancy registry, concerning a 23 year old female, who was vaccinated on 28-SEP-2006 with the first dose of Gardasil, and on 28-NOV-2006 with the second dose of Gardasil (Lot # 653735/0688F). There was no concomitant medication. The nurse reported that on 26-FEB-2007 (consumer reported as 13-MAR-2007, "some time after"she received the second dose) the patient had a miscarriage. The date of the last LMP was approximately 31-JAN-2007 ("late January"). According to the consumer, lab diagnostic tests included "several blood tests, ultrasounds, vaginal probe" (results not provided). On 29-MAR-2007, the third dose of Gardasil (Lot # 654389/0961F) was administered to the patient, and the nurse reported the patient "was fine" at that visit. The miscarriage was considered to be an other important medical event. Additional information has been requested.
It began with a sore throat and general malaise. I don't remember anything after that. I felt like I was coming down with something. I tested negative twice using a home COVID-19 test and it was negative. I went to an urgent care center on October 30th and had a COVID-19 PCR test which was positive. I took an antiviral. I was ill for 1 week. My fatigue lasted for 2 or 3 weeks. I would say I am completely recovered now.
Hospitalization for shortness of breath due to Covid diagnoses 10 days before admission on dates 04/28/2022- 04/30/2022.  Treated with dexamethasone, Remdesivir, Duoneb as needed,  Levaquin daily, zinc, vitamin C an vitamin D3
I got my Pfizer booster on the afternoon of 12/15/2021. In the early hours of the following morning, I woke up to pain and extreme swelling at the injection site. The swelling gradually got worse until it reached the size of a tennis ball. The swelling remained afterwards, but the pain finally subsided about 2 weeks later. In saw my PCP, in January 2022, because the swelling was still present. He immediately knew what it was and used medical terminology when diagnosing the issue, but I don't remember the name of the condition. He recommended that I apply ice to the area, which I did. At the time of this writing, the swelling still remains, though it is improving.
COUGH(WHOOPING COUGH LIKE SYMPTOMS),HEADACHE,HOARSENESS FOR HALF A DAY,COUGHING MORE,LITTLE SMALL BUMPS AROUND INJECTION SITE ON RIGHT LEG(NOT LIKE A RASH)MAJORITY OF BUMPS WENT AWAY,HEAD ACHE WENT AWAY,BUT STILL HAVE A MILD FEVER,STILL COUGHING
Received only one dose on 2019; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (The patient received 1st dose of Shingrix in 2019.).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-AUG-2022 Reporter's Comment: The pharmacist stated that a patient was over 70 year old that received only one dose of Shingrix on 2019. The reporter did not consent to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.).    No concomitant medication was reported.  Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 8 out of 50 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)
Mild soreness at injection site then tired and achy that night. Fine next morning. Traveled to Dr's appointment and went shopping. Upon returning home, as I carried items up 3 steps to porch, I felt my heart begin to race. Thought I was just winded in cool temp. Parked and walked to house, up flight of stairs, drank water and set down. Still my heart was racing. My Watch beeped that I might be in possible A-Fib. Daughter-in-law, an LPN, stopped to pickup our grandchild. Took my pulse, said it was rapid and irregular. Told me to take 4 baby aspirins and get to ER. EKG showed I was in A-Fib , Blood work, tests etc. Admitted to Hospital for 1 1/2 days. Given Diltiszen and shots for blood thinner, IV's. Sent home, Converted to Normal Rhythm in couple of days. Saw Dr. He switched me to Cardeilol and Xarelto. Scheduled Echo of my Heart. Results were clean and fine. Now in Lymes  (PLDS) Flareup.
This spontaneous report was received from a health care worker refers to a patient of unknown age and gender. On 02-JAN-2014 the patient was vaccinated with expired dose of ZOSTAVAX (lot # H016765; expiration date: 10-DEC-2013) (dose, route and frequency unspecified) for an unknown indication. No medical history and concomitant medications were reported. The patient has not reported or demonstrated any side effects. Outcome and causality were not reported. Additional information has been requested.
After approximately 1 week, my wrists and hands swelled up. I couldn't make a fist and had difficulty holding eating utensils as well as my tools; hammers, drills, etc. Sharp tingling and pain and numbness in both hands. Approximately 2 weeks later, my ankles and feet swelled. Also, I had tingling and pain and numbness in both ankles and feet. I felt very tired and had tremendous fatigue for approximately 2 months after the injection.  I should also mention that within a couple of weeks after the shot, I had difficulty with holding my urine. When the urge to urinate came on, I had difficulty making it to the bathroom and peed my pants. Fortunately, the urination issue is no longer a problem. However, I still have tingling, pain and numbness in my hands and feet. It makes my job very difficult since I am in the construction business.
This non-serious spontaneous case, initially received from other health professional on 20-Dec-2017, concerning a 36-year-old, adult female pregnant patient with weight 153 lb and height 65.2 inches. The patient had history of 2 previous pregnancies with 1 full term live birth and 1 was elective abortion. No family history of major congenital malformations. The patient had no history of tobacco, alcohol or illicit drug use. Concomitant medication included VITAFOL-ONE. The patient's LMP (last menstrual period) was on 17-May-2017. On 12-Aug-2017, the cystic fibrosis mutation analysis was done and the result was normal (no major congenital malformations noted). On 15-Aug-2017, the first trimester screening was done that showed increased risk of Down syndrome. On 08-Sep-2017, the amniocentesis test was done and the result was normal (no major congenital malformations noted). On 11-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (batch number: 00644623A, dose, route of administration, anatomical location, expiry date: not reported) at 16th week of pregnancy (explicitly coded as vaccine exposure during pregnancy). The outcome of the event was not reported. The EDD (estimated date of delivery) was reported on 21-Feb-2018.
Additional information received on 3/18/05. A 67 year old male received RSV vaccine or placebo and Influenza vaccine on 11/7/02 and 102 days later was admitted to the hospital for chest pain. A chest x-ray revealed bronchitis and infection of the lungs per patient. ECG and catheterization was done to rule out cardiac condition. The patient was treated with Prednisone 40mg QD from 2/17/03 to 3/3/03 and Tequin 400mg from 2/17/03 to 2/29/03. The patient recovered and was discharged on 2/22/03. The investigator assessed the events as possibly related to the study products. Follow up information received 2/28/03: Patient is a pleasant 67 year old, white male with a history of chronic intermittent upper epigastric/musculoskeletal chest pain, history of emphysema/COPD, hypothyroidism, with a recent negative Cardiolite stress test and negative GI work up, who presents with upper epigastric substernal chest pressure with shortness of breath on exertion. Patient has received negative GI work up recently with negative ultrasound of the bladder and questionable ROD for esophagitis. On admission, the patient was placed on rule out myocardial infarction. Cardiology evaluation with a recommendation of cardiac catheterization  on 2/21/03 with normal coronary arteries with 60% right common iliac lesions. The cardiac cause of pain was then ruled out. During this admission, the patient was placed on Prevacid 30mg twice a day with improvement of his upper epigastric/lower sternal chest pain. Patient is waiting for an outpatient follow up with Gastroenterology for further evaluation of his atypical chest pain which could be gastrointestinal or musculoskeletal in origin. Discharge diet is cardiac diet. Activities as tolerated. Condition is stable. Follow up in 7 to 10 days. Also follow up in gastroenterology in 7 to 10 days. Additional information received on 3/18/05. Investigator reported that discharge diagnoses were considered pre-existing conditions. Also confirmed the causality as possible. Unblinding information received on 5/16/05. The subject received Non-Adjuvanted RSV vaccine.
4/22/2021 Tested positive for COVID-19 discovered during  Universal Testing on specific Unit. Resident was asymptomatic. COVID-19 screening completed every 4 hours.  4/26/2021 Received therapeutic treatment Etesev-Bam 1400mg IV. 5/2/2021 Developed increased temperature and foul smelling urine. Rocephin 1 Gram given daily on 5/2/2021 and 5/3/2021.  5/4/2021 declining clinical presentation with fatigue. Morphine and ativan started for End Of Line/Comfort Care.  5/10/2021 Continued declining vital signs, fatigue, pain. Deceased on 5/10/2021
Temporary few minutes of mild dizziness and dry eyes, blurry vision. Patient drank orange juice. RPh observed her and talked a full conversation with her for a total of thirty minutes. Pt stated she was feeling better at 4:18 PM and perfectly fine upon leaving at 4:28PM. She stated she did not need medical attention.